Table 1.

Adverse events after the third (booster) dose of BNT162b2 vaccine in pregnant and non‐pregnant women

Adverse event	Pregnant (n = 64)	Notpregnant (n = 64)	P
Rash/local pain/local swelling	48 (75.0)	62 (96.9)	< 0.001
Diffuse rash	0 (0)	1 (1.6)	0.315
Fever	5 (7.8)	10 (15.6)	0.169
Weakness	24 (37.5)	42 (65.6)	0.001
Myalgia	14 (21.9)	32 (50.0)	0.001
Axillary lymphadenopathy	4 (6.3)	18 (28.1)	0.001
Remote lymphadenopathy	4 (6.3)	3 (4.7)	0.697
Paresthesia	4 (6.3)	4 (6.3)	1
Headache	3 (4.7)	2 (3.1)	0.648
Chest pain	0 (0)	3 (4.7)	0.042
Nausea	0 (0)	5 (7.8)	0.08
Bell's palsy	0 (0)	0 (0)	N/A
Hospitalization	0 (0)	0 (0)	N/A

Data are given as n (%).

N/A, not applicable.